Home  >  News
Eppen_SpinPro_Apr26
you can get e-magazine links on WhatsApp. Click here
News
  Cumberland Pharmaceuticals receives US FDA expanded indication approval for Caldolor injection,   April 17, 2026
  WuXi Biologics receives ISO 13485:2016 Certification, signifies capabilities in drug-device combo product development and manufacturing,   April 17, 2026
  US FDA reviews a petition to revoke approval of Roche’s top-selling drug ocrelizumab to treat primary progressive multiple sclerosis,   April 16, 2026
  GSK completes acquisition of Canada-based, clinical-stage biopharma company, 35Pharma Inc,   April 16, 2026
  Travere Therapeutics’ sparsentan receives US FDA nod to treat focal segmental glomerulosclerosis; the first and only approved medicine for FSGS,   April 15, 2026
  UK MHRA approves single-dose 7.2mg semaglutide pen to treat adult patients with obesity,   April 15, 2026
  European Commission approves Sanofi & Regeneron’s Dupixent to treat young children with chronic spontaneous urticaria,   April 15, 2026
  Daiichi Sankyo and Merck’s BLA for ifinatamab deruxtecan granted priority review in US for adult patients with ES-SCLC who experienced disease progression on or after platinum-based chemotherapy,   April 14, 2026
  Galmed announces the breakthrough development of a brain penetrating new formulation of its SCD1 inhibitor, Aramchol,   April 13, 2026
  US FDA grants tentative approval to Apotex’s semaglutide injection,   April 13, 2026
  China NMPA accepts Lynk Pharma’s NDA for zemprocitinib to treat moderate-to-severe atopic dermatitis,   April 13, 2026
  UK MHRA approves Sobi’s olezarsen for the treatment of familial chylomicronemia syndrome,   April 13, 2026
  Novo Nordisk’s Wegovy becomes first GLP-1 weight-loss treatment approved for 48 hours controlled-temperature delivery in EU,   April 11, 2026
  Ofichem unifies brands under single CDMO and pharmaceutical supplier,   April 10, 2026
  LegitScript Healthcare Merchant Certification now recognized by Google for pharmacies in India and telemedicine providers in New Zealand,   April 10, 2026
  USP's nitrosamine testing project with Vietnam NIDQC advancing global drug safety,   April 09, 2026
  Gilead Sciences to acquire Germany-based, clinical-stage biotechnology company, Tubulis GmbH,   April 09, 2026
  Merck begins tender offer to acquire Terns Pharmaceuticals,   April 09, 2026
  GSK’s Exdensur receives China NMPA approval for the treatment of chronic rhinosinusitis with nasal polyps,   April 09, 2026
  Ascletis announces FDC of ASC30, once-daily oral small molecule GLP-1R agonist, and ASC39, once-daily oral small molecule amylin-selective amylin receptor agonist, for clinical development,   April 08, 2026

 Back
 
Propak_Asia_2026
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram